Syndax Pharmaceuticals, Inc. (SNDX) is a publicly traded Healthcare sector company. As of May 21, 2026, SNDX trades at $20.23 with a market cap of $1.72B and a P/E ratio of -6.10. SNDX moved +4.08% today. Year to date, SNDX is -0.45%; over the trailing twelve months it is +90.44%. Its 52-week range spans $8.58 to $25.59. Analyst consensus is strong buy with an average price target of $39.91. Rallies surfaces SNDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for SNDX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $20.23 |
| Market Cap | $1.72B |
| P/E Ratio | -6.10 |
| EPS | $-3.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.59 |
| 52-Week Low | $8.58 |
| Volume | 222 |
| Avg Volume | 0 |
| Revenue (TTM) | $172.35M |
| Net Income | $-285.42M |
| Gross Margin | 0.00% |
12 analysts cover SNDX: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $39.91.